recombinant DNA technology
英
美 [rɪˈkɑmbɪnənt ˌdiː en ˈeɪ tekˈnɑːlədʒi]
网络 DNA重组技术; 技术; 重组DNA技术; 重组; 重组 DNA技术
双语例句
- With the development of recombinant DNA technology and expression system, quantity of known protein increases.
随着重组DNA技术的发展和表达体系的完善，已知的蛋白质数目有了很大增长。 - Method: Adopting the recombinant DNA technology, the prokaryotic expression plasmids of one normal recombinant and tree single-residue variants of bovine prion protein were constructed.
【方法】应用DNA重组技术，正确地构建牛朊蛋白基因的1个正常重组朊蛋白和3个单氨基酸变异体的原核表达载体，经转化E。 - Application of recombinant DNA technology in entomology
重组DNA技术在昆虫学中的应用 - Although the traditional amino acid producing methods such as chemical synthesis and isolation from natural sources are still utilized, the most significant trend in amino acid production technique is the swift and violent development of multiple method and biological synthesis, especially the application of recombinant DNA technology.
生物资源提取、化学合成、生物合成和综合法是生产氨基酸的4种技术，目前的发展趋势为生物合成和综合法，特别是将现代生物工程技术应用于氨基酸生产。 - The advent of recombinant DNA technology has provided efficient and cost-effective alternate sources for many therapeutic proteins.
重组DNA技术为许多治疗性蛋白的生产提供了一种有效的替代方法。 - DNA is the most important genetic material. So the method and technique of DNA extracting is the basic method for biochemistry, molecular biology and recombinant DNA technology.
DNA是最重要的遗传物质，因此，DNA的提取方法和技术是生物化学及分子生物学最基本的技术，也是生物工程最常用的技术。 - With the development of recombinant DNA and peptide synthesize technology, and advantage in analytical separation technology, more and more proteins and peptides, such as enzyme, activators and inhibitors, poly-and monoclonal antibodies, and various vaccines, are used as pharmaceuticals in clinic.
随着重组DNA和多肽合成技术的发展，更加之分析分离技术的提高，越来越多的蛋白质和多肽，象酶、活性因子、抑制因子、多克隆与单克隆抗体、疫苗，被作为药物应用于临床。 - Although we are now able to produce pharmacological peptides by recombinant DNA technology, yet we fail to produce amidated peptides in the same way because bacteria lack the a-amidase.
尽管我们能够通过重组DNA技术利用细菌生产具有药理活性的蛋白质，然而这种技术却不能用于生产酰胺化多肽，因为细菌中没有α-酰胺化酶。 - Prophylactic vaccines based on the use of virus-like particles ( VLPs) obtained from auto-assembly of L1 or L1 and L2 proteins produced by recombinant DNA technology are under phase I/ II clinical trials for HPV6/ 11 associated with condylomas.
通过DNA重组技术，基于HPV6/11型L1或L1和L2蛋白自我组装成病毒样颗粒的研究已经进入了I/II期临床实验。 - Recombinant chymosin represents one of the first successful applications of recombinant DNA technology in the food industry.
重组凝乳酶是重组DNA技术在食品工业中的首次成功应用。